A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury
Kost-Alimova, M., E. H. Sidhom, A. Satyam, B. T. Chamberlain, M. Dvela-Levitt, M. Melanson, S. L. Alper, et al. 2020. “A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib As a Candidate for Rapid Repurposing for Acute Lung Injury”. Cell Rep Med 1: 100137.